Ansbert Gadicke
10% owner at Aktis Oncology, Inc. (AKTS) since January 2026
Ansbert Gadicke has filed 70 insider reports with the SEC since March 2021, as 10% owner at Aktis Oncology, Inc. (AKTS), former 10% Owner at Werewolf Therapeutics, Inc. (HOWL) and former 10% Owner at iTeos Therapeutics, Inc. (ITOS) and at 5 more companies. In the last 12 months Ansbert Gadicke bought $20M and sold $363K of stock on the open market. In the latest filing, on January 14, 2026, Ansbert Gadicke bought 1,112,777 shares of Aktis Oncology, Inc. (AKTS) for $20M at an average of $18.00.
- Filings
- 70
- Companies
- 8
- Bought on market
- $23.9M
- Sold on market
- $128M
Companies where Ansbert Gadicke is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| 10% ownersince January 2026 | $20M | $18.00 | $16.15-10% | Jan 14, 2026 | |||
| Former 10% Owner | $3.92M | $2.09M | $16.00 | $0.9466-94% | Dec 4, 2025 | ||
| Former 10% Owner | $57.1M | May 15, 2025 | |||||
| Director, 10% owner | $132K | Jun 5, 2023 | |||||
| 10% owner | 595,489 | $8.85M | $8.89 | Feb 10, 2023 | |||
| Director, 10% owner | 30,197 | $1.28 | Aug 1, 2022 | ||||
| 10% owner | $42.5M | Jul 13, 2021 | |||||
| 10% owner | $17.1M | Jun 2, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jan 12, 2026+$20MAKTSLarge owner Gadicke Ansbert converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00)Form 4Conversion of a derivativeOpen-market purchase
- Jan 8, 2026AKTSNew insider Gadicke Ansbert claimed ownership of 341,709 sharesForm 3New insider
- Dec 4, 2025-$183KHOWLFormer 10% Owner Gadicke Ansbert sold $183,275 worth of shares (199,732 units at $0.92)Form 4Open-market sale10b5-1 plan
- Nov 25, 2025-$180KHOWLLarge owner Gadicke Ansbert sold $179,551 worth of shares (195,666 units at $0.92)Form 4Open-market sale10b5-1 plan
- Nov 20, 2025-$148KHOWLLarge owner Gadicke Ansbert sold $147,913 worth of shares (160,103 units at $0.92)Form 4Open-market sale10b5-1 plan
- Nov 17, 2025-$201KHOWLLarge owner Gadicke Ansbert sold $200,665 worth of shares (209,652 units at $0.96)Form 4Open-market sale10b5-1 plan
- Nov 12, 2025-$241KHOWLLarge owner Gadicke Ansbert sold $241,278 worth of shares (213,529 units at $1.13)Form 4Open-market sale10b5-1 plan
- Nov 6, 2025-$296KHOWLLarge owner Gadicke Ansbert sold $295,781 worth of shares (242,890 units at $1.22)Form 4Open-market sale10b5-1 plan
- Nov 3, 2025-$392KHOWLLarge owner Gadicke Ansbert sold $391,636 worth of shares (295,043 units at $1.33)Form 4Open-market sale10b5-1 plan
- Oct 29, 2025-$446KHOWLLarge owner Gadicke Ansbert sold $446,403 worth of shares (276,017 units at $1.62)Form 4Open-market sale10b5-1 plan
- May 13, 2025-$8.32MITOSFormer 10% Owner Gadicke Ansbert sold $8,317,364 worth of shares (1,031,931 units at $8.06)Form 4Open-market sale
- Mar 27, 2025-$4,605HOWLLarge owner Gadicke Ansbert sold $4,605 worth of shares (4,386 units at $1.05) and exercised 50,873 in-the-money shares at a strike of $0.09Form 4Open-market saleExercise of an in-the-money derivative
- Jun 1, 2023TCRRSEC Form 4 filed by Gadicke AnsbertForm 4Other acquisition or disposition
- May 22, 2023-$132KTCRRSEC Form 4 filed by Gadicke AnsbertForm 4Open-market saleExercise of an in-the-money derivative
- Dec 21, 2021CGEMSEC Form 5: Gadicke Ansbert increased direct ownership by 144% to 595,489 unitsForm 5Exercise or conversion of a derivative
- Jul 28, 2022KLRSSEC Form 4: Gadicke Ansbert was granted 3,253,796 sharesForm 4Grant or award
- Jun 22, 2022CGEMSEC Form 4 filed by Gadicke AnsbertForm 4Grant or award
- May 17, 2022KLRSSEC Form 4 filed by Gadicke AnsbertForm 4Grant or award
- Sep 16, 2021CGEMSEC Form 4 filed by Gadicke AnsbertForm 4Grant or award
- Jan 5, 2022-$10.5MITOSSEC Form 4: Gadicke Ansbert sold $10,452,334 worth of shares (245,469 units at $42.58)Form 4Open-market sale
- Dec 7, 2021-$2.81MITOSSEC Form 4: Gadicke Ansbert sold $2,812,428 worth of shares (83,390 units at $33.73)Form 4Open-market sale10b5-1 plan
- Dec 2, 2021-$4.82MITOSSEC Form 4: Gadicke Ansbert sold $4,817,417 worth of shares (139,773 units at $34.47)Form 4Open-market sale10b5-1 plan
- Nov 29, 2021-$1.36MITOSSEC Form 4: Gadicke Ansbert sold $1,356,825 worth of shares (38,566 units at $35.18)Form 4Open-market sale10b5-1 plan
- Nov 24, 2021-$4.74MITOSSEC Form 4: Gadicke Ansbert disposed of 15,671 shares and sold $4,744,666 worth of shares (129,617 units at $36.61)Form 4Other acquisition or dispositionOpen-market sale10b5-1 plan
- Oct 18, 2021-$785KITOSSEC Form 4: Gadicke Ansbert sold $785,384 worth of shares (28,615 units at $27.45)Form 4Open-market sale10b5-1 plan
- Oct 14, 2021-$2.58MITOSSEC Form 4: Gadicke Ansbert sold $2,584,606 worth of shares (95,002 units at $27.21)Form 4Open-market sale10b5-1 plan
- Oct 11, 2021-$2.37MITOSSEC Form 4: Gadicke Ansbert sold $2,368,800 worth of shares (87,006 units at $27.23)Form 4Open-market sale10b5-1 plan
- Oct 4, 2021-$1.25MITOSSEC Form 4: Gadicke Ansbert sold $1,247,590 worth of shares (46,130 units at $27.05)Form 4Open-market sale10b5-1 plan
- Sep 30, 2021-$972KITOSSEC Form 4: Gadicke Ansbert sold $971,730 worth of shares (35,990 units at $27.00)Form 4Open-market sale10b5-1 plan
- Sep 27, 2021-$2.48MITOSSEC Form 4: Gadicke Ansbert sold $2,484,094 worth of shares (89,476 units at $27.76)Form 4Open-market sale10b5-1 plan
- Sep 22, 2021-$1.56MITOSSEC Form 4: Gadicke Ansbert sold $1,561,394 worth of Common Stock (56,779 units at $27.50)Form 4Open-market sale10b5-1 plan
- Sep 20, 2021-$4.33MITOSSEC Form 4: Gadicke Ansbert sold $4,334,452 worth of Common Stock (152,711 units at $28.38)Form 4Open-market sale10b5-1 plan
- Sep 16, 2021-$103KCGEMSEC Form 4: Gadicke Ansbert sold $103,337 worth of Common Stock (3,556 units at $29.06), decreasing direct ownership by 0.18% to 244,551 unitsForm 4Open-market sale10b5-1 plan
- Sep 15, 2021-$2.12MITOSSEC Form 4: Gadicke Ansbert sold $2,116,733 worth of Common Stock (76,417 units at $27.70)Form 4Open-market sale10b5-1 plan
- Sep 15, 2021-$449KCGEMSEC Form 4: Gadicke Ansbert sold $449,174 worth of Common Stock (15,401 units at $29.17), decreasing direct ownership by 0.76% to 244,983 unitsForm 4Open-market sale10b5-1 plan
- Sep 13, 2021-$2.73MITOSSEC Form 4: Gadicke Ansbert sold $2,731,460 worth of Common Stock (96,456 units at $28.32)Form 4Open-market sale10b5-1 plan
- Sep 13, 2021-$774KCGEMSEC Form 4: Gadicke Ansbert sold $773,720 worth of Common Stock (26,468 units at $29.23), decreasing direct ownership by 1% to 246,853 unitsForm 4Open-market sale10b5-1 plan
- Sep 8, 2021-$2.07MITOSSEC Form 4: Gadicke Ansbert sold $2,067,786 worth of Common Stock (71,232 units at $29.03)Form 4Other acquisition or dispositionOpen-market sale10b5-1 plan
- Sep 8, 2021-$1.62MCGEMSEC Form 4: Gadicke Ansbert sold $1,616,749 worth of Common Stock (55,364 units at $29.20), decreasing direct ownership by 3% to 250,068 unitsForm 4Open-market sale10b5-1 plan
- Sep 2, 2021-$816KCGEMSEC Form 4: Gadicke Ansbert sold $816,352 worth of Common Stock (27,669 units at $29.50), decreasing direct ownership by 1% to 256,792 unitsForm 4Open-market sale10b5-1 plan
- Aug 30, 2021-$1.48MCGEMSEC Form 4: Gadicke Ansbert sold $1,476,135 worth of Common Stock (50,489 units at $29.24), decreasing direct ownership by 2% to 260,152 unitsForm 4Open-market sale10b5-1 plan
- Aug 25, 2021-$3.53MCGEMSEC Form 4: Gadicke Ansbert sold $3,531,820 worth of Common Stock (120,592 units at $29.29), decreasing direct ownership by 5% to 266,283 unitsForm 4Open-market sale10b5-1 plan
- Aug 11, 2021-$83KCGEMSEC Form 4: GADICKE ANSBERT sold $82,996 worth of Common Stock (2,857 units at $29.05), decreasing direct ownership by 0.12% to 280,921 unitsForm 4Open-market sale10b5-1 plan
- Jul 12, 2021-$2.08MRPTXSEC Form 4: GADICKE ANSBERT sold $2,082,868 worth of Common Shares (62,079 units at $33.55)Form 4Open-market sale10b5-1 plan
- Jun 29, 2021-$654KRPTXSEC Form 4: GADICKE ANSBERT sold $653,925 worth of Common Shares (19,200 units at $34.06)Form 4Open-market sale10b5-1 plan
- Jun 25, 2021-$961KRPTXSEC Form 4: GADICKE ANSBERT sold $961,457 worth of Common Shares (28,688 units at $33.51)Form 4Open-market sale10b5-1 plan
- Jun 23, 2021-$1.47MRPTXSEC Form 4: GADICKE ANSBERT sold $1,470,441 worth of Common Shares (42,798 units at $34.36)Form 4Open-market sale10b5-1 plan
- Jun 16, 2021-$207KRPTXSEC Form 4: GADICKE ANSBERT sold $207,066 worth of Common Shares (6,227 units at $33.25)Form 4Open-market sale10b5-1 plan
- Jun 9, 2021-$2.09MRPTXSEC Form 4: GADICKE ANSBERT sold $2,091,457 worth of Common Shares (61,430 units at $34.05)Form 4Open-market sale10b5-1 plan
- Jun 2, 2021-$1.19MHARPSEC Form 4: GADICKE ANSBERT sold $1,186,190 worth of Common Stock (57,494 units at $20.63)Form 4Open-market sale10b5-1 plan
- Jun 2, 2021-$1.24MRPTXSEC Form 4: GADICKE ANSBERT sold $1,237,042 worth of Common Shares (38,098 units at $32.47)Form 4Open-market sale10b5-1 plan
- May 27, 2021-$1.27MRPTXSEC Form 4: GADICKE ANSBERT sold $1,265,633 worth of Common Shares (38,559 units at $32.82)Form 4Open-market sale10b5-1 plan
- May 27, 2021-$347KHARPSEC Form 4: GADICKE ANSBERT sold $346,938 worth of Common Stock (17,159 units at $20.22)Form 4Open-market sale10b5-1 plan
- May 25, 2021KLRSSEC Form 4 filed by GADICKE ANSBERTForm 4Grant or award
- May 24, 2021-$11.3MRPTXSEC Form 4: GADICKE ANSBERT sold $11,290,421 worth of Common Shares (324,869 units at $34.75)Form 4Open-market sale10b5-1 plan
- May 24, 2021-$321KHARPSEC Form 4: GADICKE ANSBERT sold $321,030 worth of Common Stock (15,907 units at $20.18)Form 4Open-market sale10b5-1 plan
- May 20, 2021-$1.61MRPTXSEC Form 4: GADICKE ANSBERT sold $1,611,964 worth of Common Shares (46,904 units at $34.37)Form 4Other acquisition or dispositionOpen-market sale10b5-1 plan
- May 20, 2021-$982KHARPSEC Form 4: GADICKE ANSBERT sold $982,227 worth of Common Stock (47,948 units at $20.49)Form 4Open-market sale10b5-1 plan
- May 12, 2021-$1.44MHARPSEC Form 4: GADICKE ANSBERT sold $1,436,556 worth of Common Stock (68,262 units at $21.04)Form 4Open-market sale10b5-1 plan
- May 4, 2021+$3.92MHOWLSEC Form 4: GADICKE ANSBERT converted 5,965,775 units into Common Stock and bought $3,920,000 worth of Common Stock (245,000 units at $16.00)Form 4Conversion of a derivativeOpen-market purchase
- May 5, 2021-$229KHARPSEC Form 4: GADICKE ANSBERT sold $229,107 worth of Common Stock (10,172 units at $22.52)Form 4Open-market sale10b5-1 plan
- May 4, 2021-$7.39MHARPSEC Form 4: GADICKE ANSBERT sold $7,386,435 worth of Common Stock (328,519 units at $22.48)Form 4Open-market sale10b5-1 plan
- Apr 29, 2021-$2.86MHARPSEC Form 4: GADICKE ANSBERT sold $2,861,368 worth of Common Stock (130,143 units at $21.99)Form 4Open-market sale10b5-1 plan
- Apr 21, 2021-$170KHARPSEC Form 4: GADICKE ANSBERT sold $170,229 worth of Common Stock (8,972 units at $18.97)Form 4Open-market sale10b5-1 plan
- Apr 20, 2021-$727KHARPSEC Form 4: GADICKE ANSBERT sold $726,550 worth of Common Stock (38,152 units at $19.04)Form 4Open-market sale10b5-1 plan
- Apr 15, 2021-$777KHARPSEC Form 4: GADICKE ANSBERT sold $777,359 worth of Common Stock (38,556 units at $20.16)Form 4Open-market sale10b5-1 plan
- Apr 9, 2021-$5,998ITOSSEC Form 4: GADICKE ANSBERT sold $5,998 worth of Common Stock (200 units at $29.99)Form 4Open-market sale10b5-1 plan
- Apr 12, 2021-$677KHARPSEC Form 4: GADICKE ANSBERT sold $677,357 worth of Common Stock (30,928 units at $21.90)Form 4Open-market sale10b5-1 plan
- Apr 8, 2021-$1.3MITOSSEC Form 4: Ansbert Gadicke sold $1,300,850 worth of Common Stock (41,982 units at $30.99)Form 4Other acquisition or dispositionOpen-market sale10b5-1 plan
- Mar 15, 2021-$19.6MRPTXSEC Form 4: Ansbert Gadicke sold $19,585,100 worth of Common Shares (695,000 units at $28.18)Form 4Other acquisition or dispositionOpen-market sale
Also sits on boards with
Officers and directors who share two or more companies with Ansbert Gadicke.
Compare Ansbert Gadicke with
- Ansbert Gadicke vs Andrew R Allen2 shared
- Ansbert Gadicke vs Stephen W Webster2 shared
- Ansbert Gadicke vs Mary Thistle2 shared
- Ansbert Gadicke vs Morana Jovan-Embiricos2 shared
- Ansbert Gadicke vs David Hallal2 shared
- Ansbert Gadicke vs Matthew Gall2 shared
Other insiders at the same companies
- Paul L FeldmanAKTS
- Jennifer MichaelsonCGEM
- Akos CzibereAKTS
- Amy O'Leary VandekopKLRS
- Laurie KeatingKLRS
- Ken HerrmannAKTS
- Liisa Ann BaykoKLRS
- Shulamit Ron-BiggerAKTS
- Luke EvninHOWL
- MPM Oncology Innovations Fund, L.P.HOWL
- MPM Asset Management Investors BV2014 LLCHOWL
- Mpm Asset Management LLCHOWL
- MPM BioVentures 2014 (B), L.P.HOWL
- UBS Oncology Impact Fund L.P.HOWL
- MPM BioVentures 2014, L.P.ITOS
- Jacquelyn L SumerCGEM
Questions about Ansbert Gadicke
- What is Ansbert Gadicke's role at Aktis Oncology, Inc.?
- Ansbert Gadicke reports to the SEC as 10% owner at Aktis Oncology, Inc. (AKTS), according to the latest filing on January 14, 2026. Ansbert Gadicke has also filed as former 10% Owner at Werewolf Therapeutics, Inc. (HOWL), former 10% Owner at iTeos Therapeutics, Inc. (ITOS), director and 10% owner at Tcr2 Therapeutics Inc. (TCRR) and 10% owner at Cullinan Oncology, Inc. (CGEM).
- How many shares does Ansbert Gadicke own?
- After the latest filing that states it, Ansbert Gadicke directly owned 595,489 shares of Cullinan Oncology, Inc. (CGEM) and 30,197 shares of Allovir, Inc. (KLRS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Ansbert Gadicke bought or sold stock recently?
- The most recent open-market purchase was on January 12, 2026: bought 1,112,777 shares of Aktis Oncology, Inc. (AKTS) for $20M at an average of $18.00. The most recent open-market sale was on December 4, 2025: sold 199,732 shares of Werewolf Therapeutics, Inc. (HOWL) for $183K at an average of $0.92.
- How do I get alerts when Ansbert Gadicke files?
- Follow Ansbert Gadicke on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Ansbert Gadicke (SEC CIK 0001134655). Totals count each trade once, skipping amendments whose original is on file, from Mar 15, 2021 on. View on SEC EDGAR · Get this as JSON